[1] Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes[J]. J Cell Biol, 1983, 97(2):329. [2] Kalluri R. The biology and function of exosomes in cancer[J]. J Clin Invest, 2016, 126(4):1208-1215. [3] Stremersch S, De Smedt SC, Raemdonck K. Therapeutic and diagnostic applications of extracellular vesicles[J]. J Control Release, 2016, 244(Pt B):167-183. [4] Buschow SI, Nolte-'t Hoen EN,van Niel G, et al. MHC Ⅱ in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways[J]. Traffic, 2009, 10(10):1528-1542. [5] Guo BB, Bellingham SA, Hill AF. Stimulating the release of exosomes increases the intercellular transfer of prions[J]. J Biol Chem, 2016, 291(10):5128-5137. [6] Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles[J]. J Cell Sci, 2013, 126(Pt 24):5553-5565. [7] Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes[J]. Science, 2008, 319(5867):1244-1247. [8] Möbius W, Ohno-Iwashita Y, van Donselaar EG, et al. Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O[J]. J Histochem Cytochem, 2002, 50(1):43-55. [9] Guix FX, Sannerud R, Berditchevski F, et al. Tetraspanin 6:a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments[J]. Mol Neurodegener, 2017, 12(1):25. [10] Huang-Doran I, Zhang CY, Vidal-Puig A. Extracellular vesicles:novel mediators of cell communication in metabolic disease[J]. Trends Endocrinol Metab, 2017, 28(1):3-18. [11] Denzer K, Eijk MV, Kleijmeer MJ, et al. Follicular dendritic cells carry MHC class Ⅱ-expressing microvesicles at their surface[J]. J Immunol, 2000, 165(3):1259-1265. [12] Li P, Kaslan M, Lee SH, et al. Progress in exosome Isolation techniques[J]. Theranostics, 2017, 7(3):789-804. [13] Théry C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids[A]. Current Protocols in Cell Biology[M]. John Wiley & Sons, Inc. 2006:Unit 3.22. [14] Edgar JR, Eden ER, Futter CE. Hrs-and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles[J]. Traffic, 2014, 15(2):197-211. [15] Cho JA, Yeo DJ, Son HY, et al. Exosomes:a new delivery system for tumor antigens in cancer immunotherapy[J]. Int J Cancer, 2005, 114(4):613-622. [16] Mathivanan S, Fahner CJ, Reid GE, et al. ExoCarta 2012:database of exosomal proteins, RNA and lipids[J]. Nucleic Acids Res, 2012, 40(Database issue):D1241-D1244. [17] Théry C, Zitvogel L, Amigorena S. Exosomes:composition, biogenesis and function[J]. Nat Rev Immunol, 2002, 2(8):569-579. [18] Atay S, Wilkey DW, Milhem M, et al. Insights into the Proteome of gastrointestinal stromal tumors-derived exosomes reveals new potential diagnostic biomarkers[J]. Mol Cell Proteomics, 2018,17(3):495-515. [19] Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling[J]. Methods Mol Biol, 2011, 728:235-246. [20] Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J]. Cancer Cell, 2014, 25(4):501-515. [21] Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response[J]. Proc Natl Acad Sci U S A, 2012, 109(31):E2110-E2116. [22] Ogata-Kawata H, Izumiya M, Kurioka D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer[J]. PLoS One, 2014, 9(4):e92921. [23] Samsonov R, Burdakov V, Shtam T, et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer[J]. Tumour Biol, 2016, 37(9):12011-12021. [24] Rana S, Malinowska K, Zöller M. Exosomal tumor microRNA modulates premetastatic organ cells[J]. Neoplasia, 2013, 15(3):281-295. [25] Laulagnier K, Grand D, Dujardin A, et al. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes[J]. FEBS Lett, 2004, 572(1-3):11-14. [26] Fitzner D, Schnaars M, van Rossum D, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis[J]. J Cell Sci, 2011, 124(3):447-458. [27] Hao S, Bai O, Li F, et al. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity[J]. Immunology, 2010, 120(1):90-102. [28] Obregon C, Rothen-Rutishauser B, Gerber P, et al. Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway[J]. Am J Pathol, 2009, 175(2):696-705. [29] Koh E, Lee EJ, Nam GH, et al. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis[J]. Biomaterials, 2017, 121:121-129. [30] Poutsiaka DD, Schroder EW, Taylor DD, et al. Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages[J]. J Immunol, 1985, 134(1):138-144. [31] Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles[J]. J Exp Med, 2002, 195(10):1303-1316. [32] Huber V, Fais S, Iero M, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles:role in immune escape[J]. Gastroenterology, 2005, 128(7):1796-1804. [33] Hong BS, Cho JH, Kim H, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells[J]. BMC Genomics, 2009, 10:556. [34] Qu JL, Qu XJ, Zhao MF, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation[J]. Dig Liver Dis, 2009, 41(12):875-880. [35] Atay S, Banskota S, Crow J, et al. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion[J]. Proc Natl Acad Sci USA, 2014, 111(2):711-716. [36] King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells[J]. BMC Cancer, 2012, 12:421. [37] Svensson KJ, Kucharzewska P, Christianson HC, et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells[J]. Proc Natl Acad Sci U S A, 2011, 108(32):13147-13152. [38] Treps L, Perret R, Edmond S, et al. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles[J]. J Extracell Vesicles, 2017, 6(1):1359479. [39] Vella LJ. The emerging role of exosomes in epithelial-mesenchymal-transition in cancer[J]. Front Oncol, 2014, 4:361. [40] Josson S, Gururajan M, Sung SY, et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis[J]. Oncogene, 2015, 34(21):2690-2699. [41] Shedden K, Xie XT, Chandaroy P, et al. Expulsion of small molecules in vesicles shed by cancer cells:association with gene expression and chemosensitivity profiles[J]. Cancer Res, 2003, 63(15):4331-4337. [42] Takahashi K, Yan IK, Kogure T, et al. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer[J]. FEBS Open Biol, 2014, 4:458-467. [43] Mita AC, Mita MM, Nawrocki ST, et al. Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J]. Clin Cancer Res, 2008, 14(16):5000-5005. [44] Willén K, Edgar JR, Hasegawa T, et al. Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A[J]. Mol Neurodegener, 2017, 12(1):61. [45] Kranendonk MEG, Visseren FLJ, Herwaarden JA, et al. Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells[J]. Obesity Silver Spring, 2014, 22(10):2216-2223. [46] van der Graaf Y. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease[J]. Int J Cardiol, 2013, 168(3):2358-2363. [47] Kojima M, Gimenes-Junior JA, Chan TW, et al. Exosomes in postshock mesenteric lymph are key mediators of acute lung injury triggering the macrophage activation via Toll-like receptor 4[J]. FASEB J, 2018, 32(1):97-110. [48] Davis C, Dukes A, Drewry M, et al. MicroRNA-183-5p increases with age in bone-derived extracellular vesicles, suppresses bone marrow stromal (Stem) cell proliferation, and induces stem cell senescence[J]. Tissue Eng Part A, 2017, 23(21/22):1231-1240. [49] Domenis R, Zanutel R, Caponnetto F, et al. Characterization of the proinflammatory profile of synovial fluid-derived exosomes of patients with osteoarthritis[J]. Mediators Inflamm, 2017, 2017(1):4814987. |